#USA #Scottsdale #10X Health #Verséa Discovery #MitoScreen

Introduction to 10X MitoScreen™

In a groundbreaking move aimed at revolutionizing personal health assessment, 10X Health System has joined forces with Verséa Discovery to launch the pioneering 10X MitoScreen™. This next-generation mitochondrial assessment tool delivers not only critical insights into cellular energy production but also a comprehensive view of metabolic health, thereby enhancing the ability to personalize healthcare strategies.

Understanding Mitochondrial Health

Mitochondria, often referred to as the powerhouses of the cell, play a crucial role in energy production and metabolic processes. With the majority of existing tests often falling short on precision and relevance, the launch of 10X MitoScreen™ marks a significant advancement in how we evaluate mitochondrial health. This innovative approach allows both practitioners and consumers to gain deeper insights into their cellular function, performance, and overall long-term health optimization.

The Science Behind 10X MitoScreen™

The technology utilized in 10X MitoScreen™ has roots in rigorous scientific research, notably the NASA Twins Study, which aimed to understand human performance under conditions of extreme stress in space. Drawing from this prestigious foundation, the 10X MitoScreen™ offers clinically validated assessments that go beyond traditional testing methods.

Using a simple finger prick blood test, 10X MitoScreen™ evaluates various aspects of mitochondrial performance—including energy production efficiency, oxidative stress levels, and metabolic balance. By generating an integrated mitochondrial profile and score, it provides a structured analysis of an individual’s mitochondrial health, helping to track changes over time and adapt their health optimization strategies accordingly.

Benefits of Advanced Mitochondrial Insights

The insights gleaned from 10X MitoScreen™ can be transformative. Instead of merely reacting to health issues as they arise, users can now take a proactive stance by identifying possible root causes of fatigue, metabolic disorders, and other health challenges.

Brandon Dawson, Co-Founder and CEO of 10X Health System, emphasizes, "Partnering with Verséa Discovery allows us to expand access to advanced biological insights that were previously confined to research facilities. With 10X MitoScreen™, we're delivering potent capabilities that empower individuals and healthcare providers to gain a clearer picture of cellular dynamics."

Access and Features

The 10X MitoScreen™ will be available for consumers, clinicians, and enterprise partners starting in the first quarter of 2026, with early access options currently being offered for selected individuals eager to explore this transformative assessment.

Sean Fetcho, Co-Founder and CEO of Verséa Discovery, articulates that their collaboration aims to democratize access to precision health insights that were once limited to the laboratory. He remarks, "Our mission is to fuel advancements in chronic disease management and longevity science by making cellular and mitochondrial health measurable and actionable."

Conclusion

10X MitoScreen™ is not just a test; it's an evolution in how wellness is approached. By harnessing the power of data-driven insights, it assists users in steering their health journey towards a pathway of proactive care and personalized optimization. As we step into a new era of health assessment, 10X MitoScreen™ stands at the forefront, offering a promising glimpse into the future of precision wellness.

For more information and to secure your early access to 10X MitoScreen™, visit MitoScreen.com.